Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.
Clinical trial NCT06417801 · RECRUITING
Trial details
- NCT number
- NCT06417801
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-17
- Primary completion
- 2027-12-30
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.